These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1980236)

  • 61. Effect of doxazosin on plasma lipids and atherogenesis: a preliminary report.
    Kowala MC; Nicolosi RJ
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S45-9; discussion S49. PubMed ID: 2471015
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group.
    J Hum Hypertens; 1992 Jun; 6(3):181-4. PubMed ID: 1352827
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators].
    Jacob BG; Richter WO; Schwandt P
    Fortschr Med; 1993 Mar; 111(8):126-9. PubMed ID: 8099558
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The cardiovascular effects of alpha-receptor blocking agents.
    Leren P
    J Hypertens Suppl; 1992 Jun; 10(3):S11-4; discussion S14-5. PubMed ID: 1353110
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    Lehtonen A; Himanen P; Saraste M; Niittymäki K; Marniemi J
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cardiovascular effects of short-term selective alpha 1-adrenergic blockade with terazosin in patients with essential hypertension.
    Beretta-Piccoli C; Ferrier C; Weidmann P
    J Hypertens Suppl; 1985 Dec; 3(3):S231-4. PubMed ID: 2908818
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of selective alpha 1 blockers in the therapy of hypertension.
    Kaplan NM
    Am J Med; 1986 May; 80(5B):100-4. PubMed ID: 2872800
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The influence of non-beta-blocking drugs on the lipid profile: are diuretics outclassed as initial therapy for hypertension?
    Ames RP
    Am Heart J; 1987 Oct; 114(4 Pt 2):998-1006. PubMed ID: 2889346
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The place of alpha blockers in the antihypertensive armamentarium.
    Carruthers SG
    J Clin Pharmacol; 1993 Mar; 33(3):260-3. PubMed ID: 8096522
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Alpha 1 blockers. Safe, effective treatment for hypertension.
    Itskovitz HD
    Postgrad Med; 1991 Jun; 89(8):89-92, 95-8, 103-6, passim. PubMed ID: 1674822
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New developments in alpha-adrenergic receptor pharmacology: implications for the initial treatment of hypertension.
    Colucci WS
    Am J Cardiol; 1983 Feb; 51(4):639-43. PubMed ID: 6131604
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New perspectives on selective alpha 1 blockade.
    Luther RR
    Am J Hypertens; 1989 Sep; 2(9):729-35. PubMed ID: 2572243
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The pharmacological basis for the use of alpha 1-adrenoceptor antagonists in the treatment of essential hypertension.
    Davey MJ
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):5S-8S. PubMed ID: 2871856
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of in vitro and in vivo effects of prazosin on lipid metabolism.
    Kather H; Säuberlich P
    Am J Med; 1984 Feb; 76(2A):89-93. PubMed ID: 6142646
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of doxazosin on diet-induced hypercholesterolemia in C57BR/cdJ mice.
    Swindell AC; Valentine JJ
    Am J Cardiol; 1987 May; 59(14):29G-34G. PubMed ID: 2884850
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Factors influencing the lipid response to selective alpha 1-inhibition.
    Dzau VJ
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S50-2; discussion S52. PubMed ID: 2471017
    [No Abstract]   [Full Text] [Related]  

  • 78. Effect of doxazosin on cholesterol synthesis in cell culture.
    D'Eletto RD; Javitt NB
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S1-4; discussion S4. PubMed ID: 2471008
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Alpha1-adrenergic blockers: current usage considerations.
    Sica DA
    J Clin Hypertens (Greenwich); 2005 Dec; 7(12):757-62. PubMed ID: 16330901
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mechanism of the interaction of hypertension and hypercholesterolemia in atherogenesis: the effects of antihypertensive agents.
    Dzau VJ
    Am Heart J; 1988 Dec; 116(6 Pt 2):1725-8. PubMed ID: 3202079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.